Skip to main content

Sigma Solve Ltd

NSE: SIGMA BSE: 543917IT / Software

Incorporated in 2010, Sigma Solve Ltd is in the business of IT Services & Consulting[1] Sigma Solve builds state of the art custom enterprise apps that generate & maximize revenues with unique mobile app development solutions

40.1
52W: ₹30.4 — ₹65.5
PE 63.5 · Book ₹2.35 · +1606% vs book
Market Cap₹412 Cr
Stock P/E63.5Price to Earnings
ROCE33.7%Return on Capital
ROE29.4%Return on Equity
Div. Yield0.12%Face Value ₹1

Strengths

  • +Company has reduced debt.
  • +Company has delivered good profit growth of 56.7% CAGR over last 5 years
  • +Company has a good return on equity (ROE) track record: 3 Years ROE 25.9%
  • +Debtor days have improved from 81.7 to 32.2 days.

Weaknesses

  • Stock is trading at 17.3 times its book value

Shareholding Pattern

Promoters73.21%
FIIs0%
DIIs0%
Public26.78%
CategoryJun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Promoters73.22%73.22%73.22%73.22%73.22%73.22%73.22%73.21%0.0
FIIs0%0%0%0%0%0%0.03%0.00%0.0
DIIs0%0%0%0%0%0%0%0%
Public26.78%26.78%26.79%0.026.79%26.78%0.026.78%26.75%0.026.78%0.0

Financial Statements

MetricSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales6.546.788.47.917.587.968.488.5810.6310.31
Expenses5.635.595.695.875.576.316.247.187.97.42
Operating Profit0.911.192.712.042.011.652.241.42.732.89
OPM %13.91%17.55%32.26%25.79%26.52%20.73%26.42%16.32%25.68%28.03%
Net Profit0.560.821.911.631.451.081.41.251.931.9
EPS ₹0.050.080.190.160.140.110.140.120.190.18

AI Insights

Revenue Trend

TTM revenue at ₹38Cr, up 19% YoY. OPM at 24.37%.

Debt Position

Borrowings at ₹3.39Cr. Debt-to-equity ratio: 0.24x. Healthy balance sheet.

Institutional Flow

DIIs: 0% (+0.00pp change). FIIs: 0% (+0.00pp change). Promoters hold 73.21%.

Margin & Efficiency

ROCE improving from 0% (Mar 2014) to 33.69% (Mar 2025). Working capital days: -15.54.

Valuation

PE 63.5x with 33.7% ROCE. Price is 1606% above book value of ₹2.35. Dividend yield: 0.12%.

Recent Announcements